Currently out of the existing stock ratings of Ryan Macdonald, 460 are a BUY (90.73%), 46 are a HOLD (9.07%), 1 are a SELL (0.2%).

Ryan Macdonald

Work Performance Price Targets & Ratings Chart

Analyst Ryan Macdonald, currently employed at NEEDHAM, carries an average stock price target met ratio of 56.62% that have a potential upside of 24.87% achieved within 174 days.

Ryan Macdonald’s has documented 960 price targets and ratings displayed on 52 stocks. The coverage is on Technology, Healthcare, Consumer Defensive, Industrials, Consumer Cyclical, Financial Services sectors.

Most recent stock forecast was given on BNED, Barnes & Noble Education at 09-Sep-2026.

Wall Street Analyst Ryan Macdonald

Analyst best performing recommendations are on TEM (TEMPUS AI, COMMON STOCK).
The best stock recommendation documented was for TEM (TEMPUS AI, COMMON STOCK) at 11/5/2024. The price target of $56 was fulfilled within 1 day with a profit of $11.5 (25.84%) receiving and performance score of 258.43.

Average potential price target upside

of $200.06 (22.51%) on TWOU (2U).
of $93.32 (28.55%) on HUBS (HUBSPOT).
of $92.15 (16.14%) on LPSN (LIVEPERSON).

HUBS HubSpot ACCD Accolade ADBE Adobe Systems ASUR Asure Software CHGG Chegg COUP Coupa Software COUR Coursera CRM Salesforce.com DCGO DocGo DH Definitive Healthcare Corp ECOM ChannelAdvisor Corp EGAN eGain LPSN LivePerson MNTV Momentive Global MODN Model N MSFT Microsoft NRDY Nerdy ORCL Oracle PAYC Paycom Soft PFSW PFSweb PHR Phreesia TDOC Teladoc TWO Two Harbors Investments Corp TWOU 2U UDMY Udemy VEEV Veeva Systems VRNT Verint Systems YEXT Yext AMWL American Well Corp BLKB Blackbaud BNED Barnes & Noble Education DUOL Duolingo NOW ServiceNow PWSC Powerschool Holdings SVMK SVMK ZAGG ZAGG ZETA Zeta Global Holdings Corp CNC Centene Corp LH Laboratory of America Holdings THC Tenet Healthcare INST Instructure Holdings EVH Evolent Health TALK Talkspace DCBO Docebo HIMS Hims Hers Health TEM Tempus AI, Common Stock AGL agilon health PRVA Privia Health Group MOD Modine Manufacturing Company PFS Provident Financial Services SKUL Skullcandy DOCS Doximity

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Mark Murphy (JPMORGAN)

Buy Since 27-Jun-2017

$240

$11.7 (5.12%)

$425

Please subscribe to see extended stock data

Matt Vanvliet (CANTOR FITZGERALD)

Hold Since 06-Aug-2026

$200

$-28.3 (-12.40%)

$200

Please subscribe to see extended stock data

Joshua Reilly (NEEDHAM)

Buy Since 28-Nov-2022

$300

$71.7 (31.41%)

$300

Please subscribe to see extended stock data

Brian Peterson (RAYMOND JAMES)

Buy Since 06-Nov-2019

$525

7 days ago
(05-Oct-2026)

22/31 (70.97%)

$195.76 (59.46%)

247

Please subscribe to see extended stock data

Michael Turits (KEYBANK)

Buy Since 22-Nov-2020

$550

8 days ago
(04-Oct-2026)

11/12 (91.67%)

$116.5 (26.87%)

164

Please subscribe to see extended stock data

Show more analysts

Please expand the browser size to see the chart

Which stock is Ryan Macdonald most bullish on?

Potential upside of $13.87 has been obtained for VEEV (VEEVA SYSTEMS)

Which stock is Ryan Macdonald most reserved on?

Potential downside of -$3.5 has been obtained for DOCS (DOXIMITY)

What Year was the first public recommendation made by Ryan Macdonald?

On 2013